COFCO Biotechnology Co

COFCO Biotechnology Co Liabilities

The The Liabilities of COFCO Biotechnology Co (000930.SZ) as of Oct 29, 2026 is 5.75 B CNY. In the previous year, The Liabilities was 6.41 B CNY — a change of -10.28% (lower).

Liabilities

5.75 BCNY

YoY

-10.28%

Last updated:

In 2025, COFCO Biotechnology Co's total liabilities amounted to 5.75 B CNY, a -10.28% difference from the 6.41 B CNY total liabilities in the previous year.

The COFCO Biotechnology Co Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
10.64 B CNY
Jan 1, 2019
6.95 B CNY
Jan 1, 2020
9.68 B CNY
Jan 1, 2021
6.30 B CNY
Jan 1, 2022
5.59 B CNY
Jan 1, 2023
5.70 B CNY
Jan 1, 2024
6.41 B CNY
Jan 1, 2025
5.75 B CNY
The COFCO Biotechnology Co Liabilities history
YEARLiabilitiesYoY
5.75 BCNY-10.28%
6.41 BCNY+12.42%
5.70 BCNY+2.07%
5.59 BCNY-11.34%
6.30 BCNY-34.90%
9.68 BCNY+39.24%
6.95 BCNY-34.65%
10.64 BCNY+166.41%
3.99 BCNY+7.12%
3.73 BCNY-8.47%
4.07 BCNY+8.35%
3.76 BCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

COFCO Biotechnology Co Stock analysis

What does COFCO Biotechnology Co do? COFCO Biotechnology Co., Ltd. generates revenue through the production and sale of fuel ethanol, edible alcohol, starch, starch sugar, citric acid, and monosodium glutamate along with their by-products. The company's main product lines include fuel ethyl alcohol products, citric acid products and their salts, amino acid products, edible oil, and L-lactic acid products, which are distributed domestically and internationally. Domestic markets and overseas markets are the primary segments purchasing these products, with the company focusing on both industrial and consumer applications of its chemical and food-grade outputs. The firm's product portfolio spans multiple sectors including biofuels, food additives, and industrial chemicals, serving various industries through its diverse range of offerings. The company's revenue streams are derived from the sale of its core products such as fuel ethanol, citric acid, and amino acid derivatives, which are sold to industrial clients and food manufacturers. By-products from these production processes are also sold, enhancing overall profitability. The domestic market remains a key sales channel, while international distribution supports growth in overseas regions, particularly where demand for bio-based products is rising. COFCO Biotechnology leverages its production capabilities to serve both local and global customers with consistent product quality and supply. COFCO Biotechnology's business model centers on manufacturing and distributing a wide array of chemical and food-related products. Its primary customers are industrial buyers seeking raw materials for biofuel production, food processing, and chemical manufacturing. The company's product mix includes high-demand items like fuel ethanol for energy applications and citric acid for food and pharmaceutical uses. By maintaining a strong presence in both domestic and international markets, the company ensures steady revenue from multiple product lines and geographic segments. COFCO Biotechnology Co is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing COFCO Biotechnology Co's Liabilities

COFCO Biotechnology Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating COFCO Biotechnology Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing COFCO Biotechnology Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

COFCO Biotechnology Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in COFCO Biotechnology Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about COFCO Biotechnology Co stock

The Liabilities of COFCO Biotechnology Co is 5.75 B CNY in 2025.

The Liabilities of COFCO Biotechnology Co changed from 6.41 B CNY to 5.75 B CNY, representing a -10.28% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities COFCO Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's COFCO Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — COFCO Biotechnology Co

All Key Metrics — COFCO Biotechnology Co